Personalized cancer vaccines are a few years away from regulators’ approval and being available for the public, BioNTech co-founders Uğur Şahin, MD, PhD, and Özlem Türeci, MD, told the BBC Oct. 16.
Read the full post on Becker's Hospital Review - Healthcare News
